Details
Stereochemistry | ACHIRAL |
Molecular Formula | C4H7Cl3O |
Molecular Weight | 177.4567 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(C(Cl)(Cl)Cl)O
InChI
InChIKey=OSASVXMJTNOKOY-UHFFFAOYSA-N
InChI=1S/C4H7Cl3O/c1-3(2,8)4(5,6)7/h8H,1-2H3
Chlorobutanol, or trichloro-2-methyl-2-propanol, is an analgesic and sedative hypnotic in man, and an experimental general anesthetic. It has antibacterial and antifungal properties. It is also used chemical preservative for parenteral drugs. It was found, that chlorobutanol inhibited mammalian Nav 1.2 channels at concentrations less than those used to preserve parenteral solutions. Its mechanism of inhibiting Na channels differs from that of local anesthetics in that it does not show use dependent or state dependent inhibition.
Approval Year
T1/2
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
10 day EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/7159691 |
600 mg single, oral dose: 600 mg route of administration: Oral experiment type: SINGLE co-administered: |
CHLOROBUTANOL plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED |
Funbound
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
43% EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/7159691 |
600 mg single, oral dose: 600 mg route of administration: Oral experiment type: SINGLE co-administered: |
CHLOROBUTANOL plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED |
Doses
Dose | Population | Adverse events |
---|---|---|
600 mg single, oral Studied dose Dose: 600 mg Route: oral Route: single Dose: 600 mg Sources: Page: p.376 |
healthy, 20-30 n = 4 Health Status: healthy Age Group: 20-30 Sex: M Population Size: 4 Sources: Page: p.376 |
Other AEs: Sedation, Light headedness... Other AEs: Sedation Sources: Page: p.376Light headedness Euphoria |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Euphoria | 600 mg single, oral Studied dose Dose: 600 mg Route: oral Route: single Dose: 600 mg Sources: Page: p.376 |
healthy, 20-30 n = 4 Health Status: healthy Age Group: 20-30 Sex: M Population Size: 4 Sources: Page: p.376 |
|
Light headedness | 600 mg single, oral Studied dose Dose: 600 mg Route: oral Route: single Dose: 600 mg Sources: Page: p.376 |
healthy, 20-30 n = 4 Health Status: healthy Age Group: 20-30 Sex: M Population Size: 4 Sources: Page: p.376 |
|
Sedation | 600 mg single, oral Studied dose Dose: 600 mg Route: oral Route: single Dose: 600 mg Sources: Page: p.376 |
healthy, 20-30 n = 4 Health Status: healthy Age Group: 20-30 Sex: M Population Size: 4 Sources: Page: p.376 |
PubMed
Title | Date | PubMed |
---|---|---|
The actions of ether, alcohol and alkane general anaesthetics on GABAA and glycine receptors and the effects of TM2 and TM3 mutations. | 2000 Feb |
|
Structural elucidation of disinfection by-products in treated drinking water. | 2001 |
|
Effects of common ophthalmic preservatives on ocular health. | 2001 Sep-Oct |
|
Clinical inquiries. What is the best treatment for impacted cerumen? | 2002 Feb |
|
Ear drops for the removal of ear wax. | 2003 |
|
Development of a multidose formulation for a humanized monoclonal antibody using experimental design techniques. | 2003 |
|
QTc interval prolongation associated with intravenous methadone. | 2003 Oct |
|
Convenient preparation of L-arabino-hexos-5-ulose derivatives from lactose. | 2003 Oct 31 |
|
Rapid stimulation of free glucuronate formation by non-glucuronidable xenobiotics in isolated rat hepatocytes. | 2003 Sep 19 |
|
Management of earwax in primary care--postal survey of UK GPs and practice nurses. | 2004 Aug |
|
A randomised controlled study of the efficacy of hypromellose and Lacri-Lube combination versus polyethylene/Cling wrap to prevent corneal epithelial breakdown in the semiconscious intensive care patient. | 2004 Jun |
|
Allergic contact dermatitis from triethanolamine polypeptide oleate condensate in eardrops and shampoo. | 2005 Apr |
|
Preventing exposure keratopathy in the critically ill: a prospective study comparing eye care regimes. | 2005 Aug |
|
Are multidose over-the-counter artificial tears adequately preserved? | 2006 May |
|
Medication administered to children from 0 to 7.5 years in the Avon Longitudinal Study of Parents and Children (ALSPAC). | 2007 Feb |
|
Conjunctival provocation test for the diagnosis of ocular hypersensitivity to chlorobutanol. | 2007 Jan |
|
Effect of ophthalmic solution components on acrylic intraocular lenses. | 2007 Jan |
|
Development and validation of a stability-indicating analytical method for the quantitation of oxytocin in pharmaceutical dosage forms. | 2007 Jan 4 |
|
[Efficacy of an antiseptic dialysis of purulent wounds in the dentofacial region with hyvalix]. | 2007 Jul-Sep |
|
Development and evaluation of a chloramphenicol hypertonic ophthalmic solution. | 2008 Jan |
|
Ocular preservatives: associated risks and newer options. | 2009 |
|
GC determination of acetone, acetaldehyde, ethanol, and methanol in biological matrices and cell culture. | 2009 Apr |
|
Reichardt's dye and its reactions with the alkylating agents 4-chloro-1-butanol, ethyl methanesulfonate, 1-bromobutane and Fast Red B - a potentially useful reagent for the detection of genotoxic impurities in pharmaceuticals. | 2009 Apr |
|
Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells. | 2009 Apr |
|
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: the enhancing effect of potassium sorbate. | 2009 Apr 11 |
|
A Freshwater clam (Corbicula fluminea) extract reduces cholesterol level and hepatic lipids in normal rats and xenobiotics-induced hypercholesterolemic rats. | 2009 Apr 22 |
|
Randomized, placebo-controlled evaluation of chlorobutanol, potassium carbonate, and irrigation in cerumen removal. | 2009 Aug |
|
Evidence that phosphatidylinositol 3-kinase is involved in sperm-induced tyrosine kinase signaling in Xenopus egg fertilization. | 2009 Dec 17 |
|
Atlantic salmon eggs favour sperm in competition that have similar major histocompatibility alleles. | 2009 Feb 7 |
|
Methadone-associated Q-T interval prolongation and torsades de pointes. | 2009 May 1 |
|
Allergy to ophthalmic preservatives. | 2009 Oct |
|
Interactions at human ether-à-go-go-related gene channels. | 2010 Apr |
|
Efficacy and patient tolerability of travoprost BAK-free solution in patients with open-angle glaucoma and ocular hypertension. | 2010 Aug 9 |
|
Modification of cell wall properties in lettuce improves shelf life. | 2010 Feb |
|
Evaluation of acute corneal barrier change induced by topically applied preservatives using corneal transepithelial electric resistance in vivo. | 2010 Jan |
|
High gene expression of inflammatory markers and IL-17A correlates with severity of injection site reactions of Atlantic salmon vaccinated with oil-adjuvanted vaccines. | 2010 May 27 |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7689400
It was examined chlorobutanol effect on on exocrine response and intracellular Ca2+ dynamics in isolated pancreatic acini of the rat. Chlorobutanol (1 mg ml-1) markedly inhibited the secretory response to cholecystokinin octapeptide (CCK-8), carbamylcholine chloride (carbachol), or sodium fluoride, a direct G-protein activator. However, chlorobutanol itself induced a maximal release of amylase when the dose was increased to 4 mg ml-1. Chlorobutanol inhibited 13 pM [125I]-CCK-8 or 0.5 nM [3H]-methylscopolamine chloride binding to the acinar cells in a dose-dependent manner. These results indicate that chlorobutanol produces discernible pharmacological effects on the secretory response in rat pancreatic acinar cells through changes in the Ca2+ dynamics.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
98896
Created by
admin on Fri Jun 25 21:07:18 UTC 2021 , Edited by admin on Fri Jun 25 21:07:18 UTC 2021
|
||
|
WHO-ATC |
A04AD54
Created by
admin on Fri Jun 25 21:07:18 UTC 2021 , Edited by admin on Fri Jun 25 21:07:18 UTC 2021
|
||
|
EPA PESTICIDE CODE |
17501
Created by
admin on Fri Jun 25 21:07:18 UTC 2021 , Edited by admin on Fri Jun 25 21:07:18 UTC 2021
|
||
|
CFR |
21 CFR 310.538
Created by
admin on Fri Jun 25 21:07:18 UTC 2021 , Edited by admin on Fri Jun 25 21:07:18 UTC 2021
|
||
|
WHO-VATC |
QA04AD54
Created by
admin on Fri Jun 25 21:07:18 UTC 2021 , Edited by admin on Fri Jun 25 21:07:18 UTC 2021
|
||
|
WHO-VATC |
QA04AD04
Created by
admin on Fri Jun 25 21:07:18 UTC 2021 , Edited by admin on Fri Jun 25 21:07:18 UTC 2021
|
||
|
WHO-ATC |
A04AD04
Created by
admin on Fri Jun 25 21:07:18 UTC 2021 , Edited by admin on Fri Jun 25 21:07:18 UTC 2021
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
440
Created by
admin on Fri Jun 25 21:07:18 UTC 2021 , Edited by admin on Fri Jun 25 21:07:18 UTC 2021
|
PRIMARY | |||
|
HM4YQM8WRC
Created by
admin on Fri Jun 25 21:07:18 UTC 2021 , Edited by admin on Fri Jun 25 21:07:18 UTC 2021
|
PRIMARY | |||
|
C45678
Created by
admin on Fri Jun 25 21:07:18 UTC 2021 , Edited by admin on Fri Jun 25 21:07:18 UTC 2021
|
CONCEPT | Industrial Aid | ||
|
3092
Created by
admin on Fri Jun 25 21:07:18 UTC 2021 , Edited by admin on Fri Jun 25 21:07:18 UTC 2021
|
PRIMARY | |||
|
C65317
Created by
admin on Fri Jun 25 21:07:18 UTC 2021 , Edited by admin on Fri Jun 25 21:07:18 UTC 2021
|
PRIMARY | |||
|
SUB11813MIG
Created by
admin on Fri Jun 25 21:07:18 UTC 2021 , Edited by admin on Fri Jun 25 21:07:18 UTC 2021
|
PRIMARY | |||
|
CHEMBL1439973
Created by
admin on Fri Jun 25 21:07:18 UTC 2021 , Edited by admin on Fri Jun 25 21:07:18 UTC 2021
|
PRIMARY | |||
|
2761
Created by
admin on Fri Jun 25 21:07:18 UTC 2021 , Edited by admin on Fri Jun 25 21:07:18 UTC 2021
|
PRIMARY | |||
|
CHLOROBUTANOL
Created by
admin on Fri Jun 25 21:07:18 UTC 2021 , Edited by admin on Fri Jun 25 21:07:18 UTC 2021
|
PRIMARY | Description: Colourless crystals or a white, crystalline powder; odour, characteristic, camphoraceous.Solubility: Slightly soluble in water; very soluble in ethanol (~750 g/l) TS and ether R; soluble in glycerol R.Category: Antimicrobial preservative.Storage: Chlorobutanol should be kept in a tightly closed container. | ||
|
200-317-6
Created by
admin on Fri Jun 25 21:07:18 UTC 2021 , Edited by admin on Fri Jun 25 21:07:18 UTC 2021
|
PRIMARY | |||
|
5977
Created by
admin on Fri Jun 25 21:07:18 UTC 2021 , Edited by admin on Fri Jun 25 21:07:18 UTC 2021
|
PRIMARY | |||
|
DB11386
Created by
admin on Fri Jun 25 21:07:18 UTC 2021 , Edited by admin on Fri Jun 25 21:07:18 UTC 2021
|
PRIMARY | |||
|
57-15-8
Created by
admin on Fri Jun 25 21:07:18 UTC 2021 , Edited by admin on Fri Jun 25 21:07:18 UTC 2021
|
PRIMARY | |||
|
D002724
Created by
admin on Fri Jun 25 21:07:18 UTC 2021 , Edited by admin on Fri Jun 25 21:07:18 UTC 2021
|
PRIMARY | |||
|
1112503
Created by
admin on Fri Jun 25 21:07:18 UTC 2021 , Edited by admin on Fri Jun 25 21:07:18 UTC 2021
|
PRIMARY | USP-RS | ||
|
SUB06190MIG
Created by
admin on Fri Jun 25 21:07:18 UTC 2021 , Edited by admin on Fri Jun 25 21:07:18 UTC 2021
|
PRIMARY | |||
|
57-15-8
Created by
admin on Fri Jun 25 21:07:18 UTC 2021 , Edited by admin on Fri Jun 25 21:07:18 UTC 2021
|
PRIMARY | |||
|
CHLOROBUTANOL
Created by
admin on Fri Jun 25 21:07:18 UTC 2021 , Edited by admin on Fri Jun 25 21:07:18 UTC 2021
|
PRIMARY | |||
|
M3399
Created by
admin on Fri Jun 25 21:07:18 UTC 2021 , Edited by admin on Fri Jun 25 21:07:18 UTC 2021
|
PRIMARY | Merck Index | ||
|
2378
Created by
admin on Fri Jun 25 21:07:18 UTC 2021 , Edited by admin on Fri Jun 25 21:07:18 UTC 2021
|
PRIMARY | RxNorm |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)